Company intelligence / Profile preview

Predictiv Care

San Francisco, California, United Statespredictivcare.com ↗

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

Predictiv Care offers a commercialized AI-driven genomics platform that analyzes whole genome sequencing to predict risk for over 16,000 diseases and simulate response to hundreds of drugs. The solution is validated through participation in FDA challenges and partnerships with healthcare organizations. No clinical trial results are reported as the product is diagnostic/predictive rather than therapeutic.

Therapeutic areas: OtherRare Diseases
Modalities: DNA sequencingDigital health platform (AI-powered)
Industry: Molecular Diagnostics

Partnerships

Kayan Health (integration of AI-driven patient triaging with genomics)SOMOS (research partnership)

Beyond the preview

Go deeper on Predictiv Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Predictiv Care.

Explore the full profile